172 related articles for article (PubMed ID: 29478298)
1. Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation.
Arnold ML; Kainz A; Hidalgo LG; Eskandary F; Kozakowski N; Wahrmann M; Haslacher H; Oberbauer R; Heilos A; Spriewald BM; Halloran PF; Böhmig GA
Am J Transplant; 2018 Sep; 18(9):2261-2273. PubMed ID: 29478298
[TBL] [Abstract][Full Text] [Related]
2. Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival.
Wahrmann M; Döhler B; Arnold ML; Scherer S; Mayer KA; Haindl S; Haslacher H; Böhmig GA; Süsal C
Front Immunol; 2021; 12():724331. PubMed ID: 34497614
[TBL] [Abstract][Full Text] [Related]
3. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
[TBL] [Abstract][Full Text] [Related]
4. Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial.
Eskandary F; Jilma B; Mühlbacher J; Wahrmann M; Regele H; Kozakowski N; Firbas C; Panicker S; Parry GC; Gilbert JC; Halloran PF; Böhmig GA
Am J Transplant; 2018 Apr; 18(4):916-926. PubMed ID: 28980446
[TBL] [Abstract][Full Text] [Related]
5. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.
Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C
Front Immunol; 2019; 10():1208. PubMed ID: 31249568
[TBL] [Abstract][Full Text] [Related]
6. Fc-gamma IIIa-V158F receptor polymorphism contributes to the severity of Guillain-Barré syndrome.
Hayat S; Babu G; Das A; Howlader ZH; Mahmud I; Islam Z
Ann Clin Transl Neurol; 2020 Jun; 7(6):1040-1049. PubMed ID: 32484314
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation.
Diebold M; Vietzen H; Heinzel A; Haindl S; Herz CT; Mayer K; Doberer K; Kainz A; Faé I; Wenda S; Kühner LM; Berger SM; Puchhammer-Stöckl E; Kozakowski N; Schaub S; Halloran PF; Böhmig GA
Am J Transplant; 2024 May; 24(5):743-754. PubMed ID: 38097018
[TBL] [Abstract][Full Text] [Related]
8. Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.
Luque S; Lúcia M; Melilli E; Lefaucheur C; Crespo M; Loupy A; Bernal-Casas D; Gomà M; Jarque M; Crespo E; Montero N; Manonelles A; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
Am J Transplant; 2019 Feb; 19(2):368-380. PubMed ID: 30085394
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the Natural Killer Cell Receptor NKG2C Encoding
Vietzen H; Döhler B; Tran TH; Süsal C; Halloran PF; Eskandary F; Herz CT; Mayer KA; Kozakowski N; Wahrmann M; Ely S; Haindl S; Puchhammer-Stöckl E; Böhmig GA
Front Immunol; 2022; 13():829228. PubMed ID: 35401541
[TBL] [Abstract][Full Text] [Related]
10. FcgammaRIIa, IIIa and IIIb gene polymorphisms in Behçet's disease: do they have any clinical implications?
Aksu K; Kitapcioglu G; Keser G; Berdeli A; Karabulut G; Kobak S; Ozmen M; Inal V; Kabasakal Y; Oksel F; Kocanaogullari H; Doganavsargil E
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S77-83. PubMed ID: 19026120
[TBL] [Abstract][Full Text] [Related]
11. A Probabilistic Approach to Histologic Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies.
Halloran PF; Famulski KS; Chang J
Am J Transplant; 2017 Jan; 17(1):129-139. PubMed ID: 27340822
[TBL] [Abstract][Full Text] [Related]
12. Association of a coding polymorphism in Fc gamma receptor 2A and graft survival in re-transplant candidates.
Arnold ML; Fuernrohr BG; Weiß KM; Harre U; Wiesener MS; Spriewald BM
Hum Immunol; 2015 Oct; 76(10):759-64. PubMed ID: 26429312
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of complement-dependent C3d assay in kidney recipients presenting with late allograft dysfunction.
Lan JH; Gjertson D; Zheng Y; Clark S; ; Reed EF; Cecka MJ
Am J Transplant; 2018 Dec; 18(12):2934-2944. PubMed ID: 29659162
[TBL] [Abstract][Full Text] [Related]
14. Impact of FCGR2A R131H, FCGR3A F158V and FCGR3B NA1/NA2 polymorphisms on response to Fc-containing TNF inhibitors in Tunisian rheumatoid arthritis patients.
Mahmoud I; Moalla M; Ben Tekaya A; Bouden S; Rouached L; Tekaya R; Saidane O; Gorji Y; Elleuch M; Laatar A; Hamdi W; Abdelmoula L; Sfar I
Drug Metab Pers Ther; 2023 Jun; 38(2):155-162. PubMed ID: 36919284
[TBL] [Abstract][Full Text] [Related]
15. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.
Sis B; Jhangri GS; Riopel J; Chang J; de Freitas DG; Hidalgo L; Mengel M; Matas A; Halloran PF
Am J Transplant; 2012 May; 12(5):1168-79. PubMed ID: 22300601
[TBL] [Abstract][Full Text] [Related]
16. Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis.
Chen JY; Wang CM; Wu JM; Ho HH; Luo SF
Clin Exp Immunol; 2006 Apr; 144(1):10-6. PubMed ID: 16542359
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft Survival.
Wiebe C; Gareau AJ; Pochinco D; Gibson IW; Ho J; Birk PE; Blydt-Hansen T; Karpinski M; Goldberg A; Storsley L; Rush DN; Nickerson PW
Am J Transplant; 2017 Mar; 17(3):703-711. PubMed ID: 27539748
[TBL] [Abstract][Full Text] [Related]
18. Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya.
Munde EO; Okeyo WA; Raballah E; Anyona SB; Were T; Ong'echa JM; Perkins DJ; Ouma C
BMC Infect Dis; 2017 Apr; 17(1):289. PubMed ID: 28427365
[TBL] [Abstract][Full Text] [Related]
19. The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss.
Schinstock CA; Cosio F; Cheungpasitporn W; Dadhania DM; Everly MJ; Samaniego-Picota MD; Cornell L; Stegall MD
Am J Transplant; 2017 Jun; 17(6):1574-1584. PubMed ID: 27977905
[TBL] [Abstract][Full Text] [Related]
20. Kidney Intragraft Homing of De Novo Donor-Specific HLA Antibodies Is an Essential Step of Antibody-Mediated Damage but Not Per Se Predictive of Graft Loss.
Nocera A; Tagliamacco A; Cioni M; Innocente A; Fontana I; Barbano G; Carrea A; Ramondetta M; Sementa A; Basso S; Quartuccio G; Klersy C; Bertocchi M; Verrina E; Garibotto G; Ghiggeri GM; Cardillo M; Comoli P; Ginevri F
Am J Transplant; 2017 Mar; 17(3):692-702. PubMed ID: 27501275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
